Reasons for BDMARD Cessation and Subsequent Persistence of Second Line Treatment in a Large Real World Rheumatoid Arthritis (RA) Registry
|Collections||ANU Research Publications|
|Source:||Internal Medicine Journal|
There are no files associated with this item.
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.